We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.92%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$223B
AUM Growth
+$132B
Cap. Flow
+$128B
Cap. Flow %
57.4%
Top 10 Hldgs %
41.38%
Holding
5,646
New
798
Increased
2,634
Reduced
1,094
Closed
385

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.5B
2
AAPL icon
Apple
AAPL
+$1.68B
3
TSLA icon
Tesla
TSLA
+$951M
4
JNJ icon
Johnson & Johnson
JNJ
+$750M
5
UNH icon
UnitedHealth
UNH
+$703M

Sector Composition

Rank Sector Weight
1 Technology 12.48%
2 Healthcare 7.36%
3 Financials 6.5%
4 Consumer Discretionary 5.35%
5 Industrials 3.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNTM.WS
5026
DELISTED
Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PNTM.WS
$27 ﹤0.01%
333
EWG icon
5027
iShares MSCI Germany ETF
EWG
$1.6B
$25 ﹤0.01%
1
-99,570
-100% -$2.32M
GBLI icon
5028
Global Indemnity Group
GBLI
$402M
$23 ﹤0.01%
1
-2,805
-100% -$65.2K
YCBD icon
5029
cbdMD
YCBD
$4.94M
0
TDW.WS.B
5030
DELISTED
Tidewater Inc. Series B Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.B
$20 ﹤0.01%
30
WPCB.WS
5031
DELISTED
Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WPCB.WS
$20 ﹤0.01%
+3,956
New +$110
PULM icon
5032
Pulmatrix
PULM
$6.21M
$19 ﹤0.01%
5
PDYNW icon
5033
Palladyne AI Corp Warrants
PDYNW
$280K
$19 ﹤0.01%
500
SPXU icon
5034
ProShares UltraPro Short S&P 500
SPXU
$414M
-1
Closed -$347
JWSM.WS
5035
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$16 ﹤0.01%
250
AMSC icon
5036
American Superconductor
AMSC
$1.43B
$15 ﹤0.01%
4
XMAX
5037
XMAX Inc
XMAX
$558M
$15 ﹤0.01%
7
BNAIW
5038
Brand Engagement Network Warrant
BNAIW
$1.97M
$12 ﹤0.01%
1,200
EVOJW
5039
DELISTED
Evo Acquisition Corp. Warrant
EVOJW
$11 ﹤0.01%
200
LSTA icon
5040
Lisata Therapeutics
LSTA
$9.38M
$10 ﹤0.01%
4
SATX
5041
DELISTED
SatixFy Communications
SATX
$8 ﹤0.01%
+1
New +$17
SVRA icon
5042
Savara
SVRA
$1.14B
$8 ﹤0.01%
5
TZPSW
5043
DELISTED
TZP Strategies Acquisition Corp. Warrant
TZPSW
$8 ﹤0.01%
333
FCAX.WS
5044
DELISTED
Fortress Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
FCAX.WS
$8 ﹤0.01%
+2,045
New +$58
MNTN.WS
5045
DELISTED
Everest Consolidator Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A Common Stock, at an exercise price of $11.50
MNTN.WS
$8 ﹤0.01%
+500
New +$19
NGL icon
5046
NGL Energy Partners
NGL
$2.01B
$7 ﹤0.01%
6
VRN
5047
DELISTED
Veren
VRN
$7 ﹤0.01%
1
AEON.WS
5048
DELISTED
AEON Biopharma Inc
AEON.WS
$7 ﹤0.01%
+144
New +$6
PHAS
5049
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$6 ﹤0.01%
197
SWVLW icon
5050
Swvl Holdings Corp Warrant
SWVLW
$155K
$5 ﹤0.01%
238

Similar funds

Barclays's Q4 2022 Portfolio in Review

As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.

  • Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
  • Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
  • Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
  • Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
  • Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
  • Barclays opened 798 new positions and closed 385 in Q4 2022.
  • Barclays's portfolio value rose 144% quarter-over-quarter to $223B.

Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.